JP2014518267A5 - - Google Patents

Download PDF

Info

Publication number
JP2014518267A5
JP2014518267A5 JP2014518932A JP2014518932A JP2014518267A5 JP 2014518267 A5 JP2014518267 A5 JP 2014518267A5 JP 2014518932 A JP2014518932 A JP 2014518932A JP 2014518932 A JP2014518932 A JP 2014518932A JP 2014518267 A5 JP2014518267 A5 JP 2014518267A5
Authority
JP
Japan
Prior art keywords
methyl
oxabicyclo
pyrido
ethyl
naphthyridin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014518932A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014518267A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/044267 external-priority patent/WO2013003383A1/en
Publication of JP2014518267A publication Critical patent/JP2014518267A/ja
Publication of JP2014518267A5 publication Critical patent/JP2014518267A5/ja
Pending legal-status Critical Current

Links

JP2014518932A 2011-06-27 2012-06-26 細菌感染症の治療のための架橋二環式化合物 Pending JP2014518267A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161501692P 2011-06-27 2011-06-27
US61/501,692 2011-06-27
PCT/US2012/044267 WO2013003383A1 (en) 2011-06-27 2012-06-26 Bridged bicyclic compounds for the treatment of bacterial infections

Publications (2)

Publication Number Publication Date
JP2014518267A JP2014518267A (ja) 2014-07-28
JP2014518267A5 true JP2014518267A5 (cs) 2015-08-06

Family

ID=46514782

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014518932A Pending JP2014518267A (ja) 2011-06-27 2012-06-26 細菌感染症の治療のための架橋二環式化合物

Country Status (6)

Country Link
US (1) US20140243302A1 (cs)
EP (1) EP2723737A1 (cs)
JP (1) JP2014518267A (cs)
AU (1) AU2012275499A1 (cs)
CA (1) CA2840060A1 (cs)
WO (1) WO2013003383A1 (cs)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201111705D0 (en) * 2011-07-07 2011-08-24 Takeda Pharmaceutical Compounds and their use
JO3115B1 (ar) 2011-08-22 2017-09-20 Takeda Pharmaceuticals Co مركبات بيريدازينون واستخدامها كمثبطات daao
UA111861C2 (uk) 2011-11-15 2016-06-24 Такеда Фармасьютікал Компані Лімітед Ароматична гетероциклічна сполука дигідрокси
AR089929A1 (es) * 2012-02-10 2014-10-01 Actelion Pharmaceuticals Ltd Proceso para manufacturar un derivado de naftiridina
GB201222711D0 (en) 2012-12-17 2013-01-30 Takeda Pharmaceutical Novel compounds
JP6112724B2 (ja) * 2013-10-31 2017-04-12 日本化薬株式会社 1,5−ナフチリジン誘導体およびそれを有効成分として含んでなる殺虫剤
ES2669208T3 (es) 2014-01-06 2018-05-24 Bristol-Myers Squibb Company Derivados de pirrolidinilsulfona y su uso como moduladores de ROR gamma
EP3050888A1 (en) 2015-01-27 2016-08-03 Merck Sharp & Dohme Corp. Compounds for the treatment of bacterial infections
UY36851A (es) * 2015-08-16 2017-03-31 Glaxosmithkline Ip Dev Ltd Compuestos para uso en aplicaciones antibacterianas
WO2017153235A1 (de) 2016-03-09 2017-09-14 Bayer Pharma Aktiengesellschaft Substituierte n-cyclo-3-aryl-1-naphthamide und ihre verwendung
MX2018015126A (es) 2016-06-08 2019-09-02 Acraf Nuevos compuestos antibacterianos.
DK3510033T3 (da) 2016-09-09 2022-02-28 Novartis Ag Forbindelser og sammensætninger som inhibitorer af endosomale toll-lignende receptorer
CA3080804A1 (en) * 2017-11-02 2019-05-09 Calico Life Sciences Llc Modulators of the integrated stress pathway
KR20210021015A (ko) 2018-06-15 2021-02-24 브리스톨-마이어스 스큅 컴퍼니 갈렉틴-3 억제제로서의 테트라히드로피란-기재 티오디사카라이드 모방체
CN108947940A (zh) * 2018-06-20 2018-12-07 天津全和诚科技有限责任公司 一种2-氧杂环丁烷衍生物的合成方法
US20220089572A1 (en) 2019-01-14 2022-03-24 Innate Tumor Immunity, Inc. Nlrp3 modulators
WO2021252775A1 (en) 2020-06-11 2021-12-16 Chdi Foundation, Inc. Heterocyclic compounds and imaging agents for imaging huntingtin protein
MX2023006193A (es) 2020-11-26 2023-06-09 Jiangsu Hengrui Pharmaceuticals Co Ltd Compuesto triciclico fusionado, metodo de preparacion y aplicacion del mismo en medicina.
CN114957056A (zh) * 2021-02-20 2022-08-30 帕潘纳(北京)科技有限公司 制备3-甲基-2-氯-4-甲基磺酰基苯甲酸甲酯及其中间体的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR244550A1 (es) 1978-07-24 1993-11-30 Merck & Co Inc Procedimiento para obtener una composicion de antibioticos del tipo de la tienamicina con inhibidores de la dipeptidasa
BR0015545A (pt) 1999-11-12 2002-08-06 Biogen Inc Policicloalquilpurinas como antagonistas dos receptores para adenosina
JP4887297B2 (ja) * 2004-09-24 2012-02-29 アクテリオン ファーマシューティカルズ リミテッド 新規二環式抗生物質
DE102007026341A1 (de) 2007-06-06 2008-12-11 Merck Patent Gmbh Benzoxazolonderivate
JP5274553B2 (ja) * 2007-06-15 2013-08-28 アクテリオン ファーマシューティカルズ リミテッド 3−アミノ−6−(1−アミノ−エチル)−テトラヒドロピラン誘導体
KR101658681B1 (ko) * 2008-06-03 2016-09-21 액테리온 파마슈티칼 리미티드 항균제로서 [4-(1-아미노-에틸)-사이클로헥실]-메틸-아민 및 [6-(1-아미노-에틸)-테트라하이드로-피란-3-일]-메틸-아민 유도체
EP2352734A1 (en) * 2008-10-17 2011-08-10 Glaxo Group Limited Tricyclic nitrogen compounds used as antibacterials
TW201022279A (en) * 2008-11-14 2010-06-16 Astrazeneca Ab Chemical compounds
US8211890B2 (en) * 2008-12-12 2012-07-03 Actelion Pharmaceuticals 5-amino-2-(1-hydroxy-ethyl)-tetrahydropyran derivatives
AR076222A1 (es) * 2009-04-09 2011-05-26 Actelion Pharmaceuticals Ltd Derivados 2-hidroxietil-1h-quinolin-ona y sus analogos azaisotericos con actividad antibacteriana y composiciones farmaceuticas que los contienen

Similar Documents

Publication Publication Date Title
JP2014518267A5 (cs)
JP2019536768A5 (cs)
RU2007147413A (ru) Аминопиперидинхинолины и их азаизостерические аналоги с антибактериальной активностью
JP2014513139A5 (cs)
JP2015514808A5 (cs)
JP2008540529A5 (cs)
HRP20192197T2 (hr) Derivati karbazola
JP2013537210A5 (cs)
TW200538128A (en) Therapeutic combinations of atypical antipsychotics with corticotropin releasing factor antagonists
CA2607151A1 (en) Hiv integrase inhibitors
JP2017520607A5 (cs)
MD3250208T2 (ro) 7-Benzil-4-(4-(trifluorometil)benzil)-1,2,6,7,8,9-hexahidroimidazo[1,2-a]pirido[3,4-e]pirimidin-5(1h)-onă și sărurile acesteia și utilizarea lor în terapie
EP4249076A3 (en) (s)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-2-methoxy-n-(pyridin-2-yl)benzamide as btk-inhibitor
ZA200308696B (en) Nitrogen-containing bicyclic heterocycles for use as antibacterials.
PE20081581A1 (es) COMPUESTOS PIRROLO[2,3-b]PIRIDINAS COMO MODULADORES DE QUINASA
SG172958A1 (en) Poly (adp-ribose) polymerase (parp) inhibitors
RU2014112931A (ru) Пиразолохинолиновое производное
JP2013500247A5 (cs)
RU2014123109A (ru) Антибиотические производные 2-оксо-оксазолидин-3, 5-диила
JP2014521751A (ja) 腎髄質外層カリウムチャンネルの阻害薬
JP2003528096A5 (cs)
MD3532067T2 (ro) Formă farmaceutică lipozomală pentru utilizare în tratamentul cancerului
RU2011117412A (ru) Трициклические оксазолидиноновые антибиотические соединения
RU2350616C2 (ru) Производные пиразоло- и имидазопиримидина
JP2014513140A5 (cs)